Change of Nominated Adviser
Oxford BioDynamics Plc has appointed Singer Capital Markets Advisory LLP as its new Nominated Adviser and Broker, effective immediately. This change in advisory and brokerage services is the primary focus of the announcement.
Select text to share a quote on X · sign in to keep highlights & notes in your OBD notes
Oxford, UK - 17 February 2026 - Oxford BioDynamics Plc (AIM: OBD, the Company), a precision clinical diagnostics company bringing specific and sensitive tests to the practice of medicine based on its EpiSwitch® 3D genomics platform, announces that it has today appointed Singer Capital Markets Advisory LLP as Nominated Adviser and Broker to the Company.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.